SEC
AGIO icon

Seven Eight Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Seven Eight Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-39,262
Closed -$1.69M – 692
2024
Q2 		$1.69M Buy
+39,262
New +$1.42M 0.18% 187
2019
Q4 		– Sell
-7,186
Closed -$233K – 611
2019
Q3 		$233K Buy
+7,186
New +$297K 0.01% 564
2016
Q3 		– Sell
-22
Closed -$1K – 337
2016
Q2 		$1K Buy
+22
New +$1.09K ﹤0.01% 510
2015
Q4 		– Sell
-200
Closed -$14K – 539
2015
Q3 		$14K Buy
+200
New +$19.5K 0.01% 429
2015
Q2 		– Sell
-500
Closed -$47K – 520
2015
Q1 		$47K Sell
500
-3,300
-87% -$370K 0.08% 292
2014
Q4 		$426K Buy
+3,800
New +$339K 0.71% 31

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Seven Eight Capital's AGIO Position: Q3 2024 in Review

Seven Eight Capital sold out of Agios Pharmaceuticals (AGIO) in Q3 2024, closing a stake of 39,262 shares — an estimated $1.69M sold.

Seven Eight Capital first reported a position in AGIO in Q4 2014 and held it in 6 quarters. The position peaked at $1.69M in Q2 2024. 207 funds tracked by Wall St. Rank hold AGIO as of Q3 2024.

  • Seven Eight Capital reported no remaining Agios Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Seven Eight Capital sold 39,262 Agios Pharmaceuticals shares in Q3 2024, an estimated $1.69M.
  • Seven Eight Capital first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 6 quarters.
  • Seven Eight Capital's Agios Pharmaceuticals position peaked at $1.69M in Q2 2024.
  • 207 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2024.

Based on Seven Eight Capital's 13F filing for Q3 2024, filed 12 Nov 2024.